CION Cancer Clinics
Should everyone be tested for cancer genes, not just high-risk families? | CION Cancer Clinics
Today, genetic testing is offered mainly to families with a strong history. Some specialists argue that misses too many carriers with no family clues at all. This page explains both sides of that debate, where population screening actually stands today, and why your own decision about testing does not need to wait for it to be settled. At CION Cancer Clinics in Hyderabad, our oncologists review your family history with you and guide you to the right genetic counselling and testing.
On this page
- Why don't we just test everyone for cancer genes?
- What the argument actually comes down to
- Is anyone actually doing population screening today?
- Words that come up in this debate
- Criteria-based testing vs population screening
- What people get wrong about this debate
- What this page cannot tell you
- Common questions about population genetic screening
The debate, plainly
Why don't we just test everyone for cancer genes?
Because most people who would test positive have no family history to warn them, but testing every healthy adult also finds far more uncertain results than useful ones. Whether that trade is worth it, for a whole population rather than one family, is genuinely unsettled among specialists.
What "population screening" actually means here
Today, genetic testing for cancer risk is offered mainly to people whose family history or personal diagnosis meets set criteria. Population screening would flip that: testing everyone, or a whole birth cohort, for a short panel of well-understood faults regardless of family history.
Why the idea keeps coming back
Family-history-based testing misses people whose relatives died young of other causes, were never diagnosed, or simply never spoke about illness. A carrier with no family clues to follow can go unrecognised for a lifetime under the current approach, which is the strongest argument in favour of screening more broadly. Small families, and families where women's health was never discussed openly, are particularly likely to hide a real pattern behind what looks like an unremarkable history.
Nobody serious is proposing to test for every gene in every person. The debate is about a small, well-studied set of faults, not a general scan of your genome.Both sides
What the argument actually comes down to
Specialists on both sides agree on the biology. They disagree on what a health system should do with it.
The case for screening more broadly
A meaningful share of carriers have no family pattern to flag them. Broader screening would find these people before a diagnosis, when earlier scans or preventive options still matter most.
The case for staying targeted
Testing only where family history or personal diagnosis points to it keeps results interpretable and keeps counselling resources aimed at people who are actually likely to carry a fault.
The uncertain-result problem
Testing many more healthy people produces many more uncertain variants nobody yet understands, which can cause worry without changing a single decision about care.
The system-capacity problem
Every positive result needs a counsellor to explain it properly. Screening a whole population would need far more trained counsellors than most health systems, including India's, currently have.
Not sure whether this applies to you?
Ask an oncologistWhere things actually stand
Is anyone actually doing population screening today?
-
Small pilot programmes exist
A handful of health systems abroad have piloted offering a limited panel to specific communities where a founder fault is common, rather than to entire populations.
-
Professional bodies remain cautious
Most major genetics organisations still recommend criteria-based testing as the default, while acknowledging the gap it leaves for undiagnosed carriers.
-
India has no population programme
Testing here remains overwhelmingly criteria-based: a personal or family history that meets a recognised threshold, assessed by a counsellor case by case.
-
The evidence base is still growing
Studies comparing outcomes between screened and unscreened populations are still relatively new, which is part of why the debate has not settled either way.
-
What is likely to change first
Most specialists expect targeted expansion, such as offering testing to specific communities with a known founder fault, well before any move toward testing an entire general population.
On this topic
Words that come up in this debate
- Population screening
- Offering a test to everyone in a defined group, regardless of personal or family history, rather than only to those who meet criteria.
- Criteria-based testing
- Today's usual approach: testing only when family history or a personal diagnosis meets an agreed threshold.
- Founder fault
- A specific gene change common in one community because it was present in a shared ancestor generations ago.
- Uninformative negative
- A negative result in someone whose family has never had a fault confirmed. It does not rule out an inherited cause.
- Cascade testing
- Testing close relatives of someone found to carry a fault, one family at a time, rather than testing a whole population at once.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
Criteria-based testing vs population screening
Commonly believed
What people get wrong about this debate
The actual proposals discussed are for a small, well-studied panel of genes linked to cancer, not a full genetic scan. The scope being debated is far narrower than it sounds.
Cost, counselling capacity and evidence all differ by country. A pilot succeeding in one health system does not mean it transfers cleanly to another with fewer trained counsellors.
Opponents accept the same biology. Their concern is about capacity and unintended harm from uncertain results, not doubt about whether inherited faults exist.
It affects how quickly testing is offered in your community, particularly where a founder fault is already known. Community-specific pilots are the most likely first change here.
Being straight with you
What this page cannot tell you
It cannot tell you whether population screening will ever reach India, or when. That decision sits with health policy makers and professional bodies, weighing evidence that is still accumulating, not with any single clinic.
It cannot replace assessing your own family
Whatever happens to policy, your own decision about testing today still depends on your family history, assessed properly by a counsellor. This debate is background, not a reason to wait or to rush. Treat it as context for a conversation you can have now, not as a reason to postpone that conversation until the policy question is settled.
Who this does not apply to
If your family already meets recognised testing criteria, this debate changes nothing about your own next step. Talk to a counsellor now rather than waiting for a policy that may be years away.
If you are unsure whether your family qualifies under current criteria, call the helpline and describe your history. Someone will tell you plainly where you stand.Questions we are asked
Common questions about population genetic screening
Is population screening the same as a general health check-up?
No. It refers specifically to offering a targeted panel of cancer-related genes to everyone in a group, regardless of symptoms, rather than a general medical check-up covering unrelated conditions.
Can I ask for this kind of broad testing myself in India today?
Panel testing exists here, but it is offered case by case through a counsellor assessing your history, not as an open population programme. You can still discuss a panel test if your situation warrants it.
Why do more uncertain results matter so much?
An uncertain result cannot guide treatment or screening decisions, but it can cause lasting worry and sometimes leads to actions that are not supported by evidence. Managing that well needs a trained counsellor, at scale.
Does this debate affect people who already have cancer?
Not directly. Someone already diagnosed is usually tested through the criteria-based route already, based on their own diagnosis, regardless of how this broader policy question is eventually settled.
Are there any population programmes running anywhere yet?
A small number of pilot programmes exist abroad, often aimed at one community with a known founder fault rather than an entire national population. Full national programmes are not yet established anywhere.
Would this ever be compulsory?
No serious proposal makes genetic testing compulsory. Every version discussed, including pilots already run abroad, has been offered with the choice to decline.
How does this connect to founder faults in Indian communities?
Some communities in India carry a specific fault more often because of shared ancestry and marriage within the community. A targeted offer to such a community is closer to what is being piloted elsewhere than a general population programme.
Where can I read more about whether my own family qualifies?
Start with a note of who in your family had cancer and at roughly what age. A genetic counsellor can tell you, under today's criteria, whether testing is worth pursuing now.
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. One helpline books a consultation at any of these centres, and your team will tell you where counselling and testing take place.
Sources
- National Cancer Institute — Genetic Testing for Inherited Cancer Susceptibility Syndromes
- Cancer Research UK — Inherited cancer genes and increased cancer risk
- NHS — Predictive genetic tests for cancer risk genes
- MedlinePlus Genetics — What does it mean to have a genetic predisposition to a disease?
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Not sure whether your own family already qualifies?
This debate is about future policy. Your own next step depends on your family history today. Tell us who was diagnosed and we will tell you honestly where you stand. One helpline serves every CION centre.